Turbo-charged SK Hynix volatility shows no sign of abating as AI euphoria swings to fatigue
SK Hynix shares continued their rollercoaster ride Thursday with a 12% collapse following on from Wednesday’s near 9% jump.
SK Hynix shares continued their rollercoaster ride Thursday with a 12% collapse following on from Wednesday’s near 9% jump.
Security controls are designed to stop bad payments, but new data suggested the strongest systems may be the ones customers barely notice. The PYMNTS Intelligence report “When Controls Slow Commerce: The Data Behind Middle-Market Payment Friction,” the latest installment of the 2026 Certainty Project, found that many firms still struggle to protect transactions without delaying…
Key Points Tesla is the EV leader and is looking to tap into several transformational opportunities. Rivian could ride a strong tailwind from a new model launch and its efforts to achieve self-driving capabilities. One of these stocks looks much more attractive than the other. These 10 stocks could mint the next wave of millionaires…
Virtu Financial, Inc. (NYSE: VIRT) has released preliminary estimated results for the second quarter of 2026, revealing solid financial performance as the global market maker and financial services technology provider moves to raise additional debt financing. The New York based firm expects net income of $285 million for the quarter ended June 30, 2026, with…
Need a new dividend stock you know you can count on? The usual suspects like Coca-Cola and Procter & Gamble remain solid options. You may have better luck, however, with a dividend stock that has an equally strong track record that’s a bit off the beaten path. That’s Dividend King Illinois Tool Works (ITW +0.14%)….
Three established property professionals have taken up new roles across the residential sector, signalling continued structural shifts in the industry towards brokerage and franchise models. Moveli appoints former Hamptons director Andrew Farmer has joined Moveli after more than 25 years in estate agency, including nearly two decades as a director at Hamptons. Farmer, who specialises…
HONG KONG, July 14, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) today announced that it has entered into a collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) to advance a Phase II clinical study evaluating a cadonilimab-based combination regimen for the perioperative treatment of locally advanced, resectable HER2-negative gastric or gastroesophageal junction…